New

DCVC Bio

The AI engine Fit Assessment

Beta

The company demonstrates a deep-tech orientation with a clear focus on industrial applications and targets energy-intensive sectors through investments in life sciences, AI-enabled biotech, and related deep-tech infrastructure that transform large industries.

Blurb

DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.

HQ Location

San Francisco (United States)

Founded

2018

Employees

11 - 50

Total funding raised

Not available

Funding Status

Not available

DCVC and its principals have backed brilliant people changing global-scale industries for over twenty years, helping create tens of billions of dollars of wealth for founders, employees, and our investors while also making the world a markedly better place.



DCVC brings to bear a unique model that unites a team of experienced venture capitalists with more than 35 technology executives and experts (CTOs, CIOs, Chief Scientists, Principal Engineers, Professors at Stanford and Berkeley) with significant tenures at top 100 technology companies and research institutions worldwide. DCVC focuses on seed, Series A, and growth stage companies that apply deep compute, big data and IT infrastructure technologies to transform giant industries.



Learn more about us at www.dcvc.com, read our thinking at https://medium.com/@dcvc, and follow us on twitter at @dcvc.